drugset / Trial / NCT03774355
Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this open-label, randomized, 2\*2 crossover study is to compare the safety and Pharmacokinetics CG1801 and CGL1802 in Healthy Volunteers.
Timeline
- Start
- 2018-12-17
- Primary completion
- 2019-05-03
- Completion
- 2019-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Polmacoxib | Other / unclassified | 2 mg | — |
Indications
No indication recorded.